SCHEMBL15097572

SCHEMBL15097572

COC(=O)c1nc2c(N=C(c3ccccc3)c3ccccc3)cc(N3CCOCC3)cn2c(=O)c1OCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.45
PIK3CA P42336 2/20 0.40
PIK3CB P42338 2/20 0.40
HPGD P15428 2/20 0.39
LMNA P02545 1/20 0.39
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 3/20 0.38
MAPK1 P28482 1/20 0.38
MAPT P10636 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PRKDC P78527 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
MAPK14 Q16539 1/20 0.37
ALKBH1 Q13686 1/20 0.37
CYP3A4 P08684 1/20 0.36
LRRK2 Q5S007 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10070084 0.90 MRGPRX4 (0.39) MRGPRX4PIK3CAPIK3CBHPGDLMNA
SCHEMBL367770 0.86 MRGPRX4 (0.45) MRGPRX4PIK3CAPIK3CBHPGDLMNA
SCHEMBL1221944 0.86 MRGPRX4 (0.45) MRGPRX4PIK3CAPIK3CBHPGDLMNA
SCHEMBL12880836 0.85 MRGPRX4 (0.44) MRGPRX4PIK3CAPIK3CBHPGDLMNA
SCHEMBL15091802 0.83 KDM4E (0.44) MRGPRX4PIK3CAPIK3CBHPGDLMNA
SCHEMBL12880835 0.83 MRGPRX4 (0.43) MRGPRX4PIK3CAPIK3CBHPGDLMNA
SCHEMBL15092128 0.82 MRGPRX4 (0.42) MRGPRX4PIK3CAPIK3CBHPGDLMNA
SCHEMBL1221123 0.81 MRGPRX4 (0.43) MRGPRX4PIK3CAPIK3CBHPGDLMNA
SCHEMBL1222306 0.81 MRGPRX4 (0.43) MRGPRX4PIK3CAPIK3CBHPGDLMNA
SCHEMBL1222487 0.81 MRGPRX4 (0.41) MRGPRX4PIK3CAPIK3CBHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130178469-A1 NOVEL ANTIVIRAL AGENTS SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (SIOC) (CN) 2013-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178469-A1 NOVEL ANTIVIRAL AGENTS EIF2AK2, IFNAR1, IRF3 MRGPRX4 313/4885PIK3CA 1532/4885PIK3CB 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.